Novel spectacle lens design: Use of lenses may reduce the rate of progression of juvenile myopia
Spectacle lenses: Use of lenses may reduce the rate of progression of juvenile myopia
This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.
| Facility | City | Region | Status |
|---|---|---|---|
| Aier Eye Hospital | Changsha | China | |
| West China Hospital | Chengdu | China | |
| Zhongshan Ophthalmic Center | Guangzhou | China | |
| Fudan University EENT | Shanghai | China | |
| Tianjin Eye Hospital | Tianjin | China |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05562622 on ClinicalTrials.gov ↗ ← All trials in China